Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Cancer Research Technology Ltd.
DescriptionSingle chain Fv mAb against carcinoembryonic antigen (CEA)
Molecular Target
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase I
Standard Indication Cancer (unspecified)
Indication DetailsAutologous T cell therapy
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today